Gelteq (GELS) Prepaid Assets (2023 - 2025)

Gelteq's (GELS) quarterly Prepaid Assets came in at $173502.1 in Q4 2025, down 83.29% year-on-year from $1.0 million in Q4 2024, and down 48.16% quarter-over-quarter from $334661.6 in Q2 2025.

Gelteq (GELS) Prepaid Assets (2023 - 2025) Analysis & Trends

Gelteq's Prepaid Assets history runs 3 years deep, the most recent figure standing at $173502.1 for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 83.29% year-over-year to $173502.1 in Q4 2025; TTM through Dec 2025 was $173502.1, a 83.29% decrease from a year earlier, with the FY2025 full-year figure at $334661.6, up 430.63% from the prior year.
  • Prepaid Assets slipped to $173502.1 in Q4 2025 per GELS's latest filing, from $334661.6 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.0 million in Q4 2024 and bottomed at $63068.6 in Q2 2024.
  • The 3-year median for Prepaid Assets is $173502.1 (2025), against an average of $342099.4.
  • Biggest YoY gain for Prepaid Assets was 430.63% in 2025; the steepest drop was 83.29% in 2025.
  • Year by year, Prepaid Assets stood at $101094.9 in 2023, then jumped by 926.93% to $1.0 million in 2024, then sank by 83.29% to $173502.1 in 2025.
  • Per Business Quant, the three latest GELS Prepaid Assets figures stand at $173502.1 (Q4 2025), $334661.6 (Q2 2025), and $1.0 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Gelteq 740.00 -47,821.64 -

Historic Data

Download Data
DateValue
Dec 31, 2025 173,502.06
Jun 30, 2025 334,661.57
Dec 31, 2024 1.04 Mn
Jun 30, 2024 63,068.64
Jun 30, 2023 101,094.86